CX3CR1 and neoplasm: Tumor vaccine greatly boosted CX3CR1+ subset in TDLN, especially for Tgfbr2−/− cells (Fig. S3a and S3b), leading to significantly increased accumulation of this effector subset in the tumors (Fig. S3c).